Pfizer, Nvidia Support AI Drug Discovery company
Pfizer, Nvidia Support AI Drug Discovery Company Discover how CytoReason, backed by Pfizer and Nvidia, is using AI to accelerate drug discovery and model human diseases for faster, safer treatments. Massive Investment Fuels AI-Powered Innovation CytoReason, an AI-driven company, recently secured an $80 million funding round. This investment will help bring its … Read more